Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Anthony David Elias

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Elias, Anthony

Item TypeName
Academic Article Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
Academic Article An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
Academic Article Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
Academic Article A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients.
Academic Article Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma.
Academic Article Dana-Farber Cancer Institute studies in advanced sarcoma.
Academic Article Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.
Academic Article A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.
Academic Article High-dose ifosfamide with mesna uroprotection: a phase I study.
Academic Article Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
Academic Article Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
Academic Article Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study.
Concept Mesna

Search Criteria
  • Mesna

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)